BVT Aktienanleihe AMZN 31.12.2024/ DE000VM3PR47 /
21/05/2024 10:34:38 | Diferencia0.000 | Bid12:43:46 | Ask12:43:46 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
100.930EUR | 0.00% | 100.940 Volumen de oferta: 50,000 |
101.040 Tamaño/ Volumen/ Formato de Ask: 50,000 |
Amazon.com Inc | 100.00 USD | 31/12/2024 | Call |
GlobeNewswire
13:15
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
GlobeNewswire
13:10
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession Licen...
GlobeNewswire
13:07
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
GlobeNewswire
13:05
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
13:00
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
GlobeNewswire
13:00
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
13:00
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
13:00
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on AB...
GlobeNewswire
13:00
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC)...
GlobeNewswire
13:00
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
GlobeNewswire
13:00
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
GlobeNewswire
13:00
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therap...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página